Prognostic significance of plasma scatter factor/hepatocyte growth factor levels in patients with metastatic hormone-refractory prostate cancer: Results from cancer and leukemia group B 150005/9480
Peter A. Humphrey, Susan Halabi, Joel Picus, Ben Sanford, Nicholas J. Vogelzang, Eric J. Small, Philip W. Kantoff
Dive into the research topics of 'Prognostic significance of plasma scatter factor/hepatocyte growth factor levels in patients with metastatic hormone-refractory prostate cancer: Results from cancer and leukemia group B 150005/9480'. Together they form a unique fingerprint.